Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial

Martin Blackstein, C. L. Vogel, R. Ambinder, J. Cowan, J. Iglesias, A. Melemed

Research output: Contribution to journalArticlepeer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences